Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial-Reference-Cited by-同舟云学术

Short-term androgen suppression and radiotherapy versus intermediate-term androgen suppression and radiotherapy, with or without zoledronic acid, in men with locally advanced prostate cancer (TROG 03.04 RADAR): 10-year results from a randomised, phase 3, factorial trial

Published:2019-02 Issue:2 Volume:20 Page:267-281
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Denham James W,Joseph David,Lamb David S,Spry Nigel A,Duchesne Gillian,Matthews John,Atkinson Chris,Tai Keen-Hun,Christie David,Kenny Lizbeth,Turner Sandra,Gogna Nirdosh Kumar,Diamond Terry,Delahunt Brett,Oldmeadow Chris,Attia John,Steigler Allison

Publisher

Elsevier BV

Subject

Oncology

Reference32 articles.

1. Hormonal therapy and radiotherapy for localized prostate cancer: who, where and how long?;Roach;J Urol,2003

2. Controversies in the treatment of high-risk prostate cancer—what is the optimal combination of hormonal therapy and radiotherapy: a review of literature;Al-Mamgani;Prostate,2010

3. Picking the optimal duration of hormonal therapy in men with high-risk and locally advanced prostate cancer treated with radiotherapy;Denham;Semin Radiat Oncol,2013

4. Short-term neoadjuvant androgen deprivation and radiotherapy for locally advanced prostate cancer: 10-year data from the TROG 96.01 randomised trial;Denham;Lancet Oncol,2011

5. Improved survival in patients with locally advanced prostate cancer treated with radiotherapy and goserelin;Bolla;N Engl J Med,1997

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCL2/CCR2 Expression in Locally Advanced Prostate Cancer and Patient Long-Term Outcome: 10-Year Results from the TROG 03.04 RADAR Trial;Cancers;2024-08-08

2. Treatment intensification strategies for men undergoing definitive radiotherapy for high-risk prostate cancer;World Journal of Urology;2024-03-16

3. Enhancing Androgen Deprivation Therapy (ADT) integration in prostate cancer: Insights for Stereotactic Body Radiotherapy (SBRT) and brachytherapy modalities;Clinical and Translational Radiation Oncology;2024-03

4. Can Extreme Dose Escalation With External Beam Radiation Therapy and Low-Dose-Rate Brachytherapy Boost Obviate the Need for Long-Term Androgen Deprivation Therapy in Patients With High-Risk Localized Prostate Cancer?;International Journal of Radiation Oncology*Biology*Physics;2024-02

5. Effects of neoadjuvant zoledronate and radiation therapy on cell survival, cell cycle distribution, and clinical status in canine osteosarcoma;Frontiers in Veterinary Science;2024-01-31